申请人:Volk Balazs
公开号:US20070232619A1
公开(公告)日:2007-10-04
The present invention is concerned with new 3,3-disubstituted indol-2-one derivatives of the general Formula (I), wherein R
1
stands for hydrogen, halogen, alkyl having 1-7 carbon atom(s) or sulfonamido; R
2
represents hydrogen or halogen; R
3
denotes hydrogen, alkyl having 1-7 carbon atom(s) optionally carrying an aryl substituent or aryl optionally carrying one or two halogen substituent(s); R
4
stands for alkyl having 1-7 carbon atom(s); R
5
represents a group of the general Formula (II a) or (II b), wherein Q and W each represents nitrogen or CH; R
6
, R
7
and R
8
each stands for hydrogen, halogen, trifluoromethyl, alkyl or alkoxy having 1-7 carbon atom(s), or R
6
and R
7
together represent ethylenedioxy; m is 0, 1, or 2; a is a single, double or triple bond; n is 0, 1 or 2; and pharmaceutically acceptable acid addition salts thereof which are useful in the treatment or prophylaxis of diseases of the central nervous system, the gastrointestinal system and the cardiovascular system.
本发明涉及一般式(I)的新的3,3-二取代吲哚-2-酮衍生物,其中R1代表氢、卤素、具有1-7个碳原子的烷基或磺胺基;R2代表氢或卤素;R3代表氢、具有1-7个碳原子的烷基,可选地带有芳基取代基,或芳基,可选地带有一个或两个卤素取代基;R4代表具有1-7个碳原子的烷基;R5代表一般式(II a)或(II b)的基团,其中Q和W各自代表氮或CH;R6、R7和R8各自代表氢、卤素、三氟甲基、具有1-7个碳原子的烷基或烷氧基,或R6和R7一起代表乙二氧基;m为0、1或2;a为单键、双键或三键;n为0、1或2;以及其药学上可接受的酸盐,用于治疗或预防中枢神经系统、消化系统和心血管系统疾病。